(Total Views: 376)
Posted On: 08/25/2020 2:35:51 PM
Post# of 58

$SRPT News Article - Sarepta Therapeutics Announces FDA Acceptance of Casimersen (SRP-4045) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45 https://marketwirenews.com/news-releases/sare...14793.html


My Twitter: WhyteStocks